Showing results (11-20 of 116) with videos related to
Sort By:
Pageof 12
Expert Opinion on Drug Delivery|April 23, 2008
Current and future testosterone delivery systems for treatment of the hypogonadal maleEmily Pfeil, Adrian S DobsTouchreviews in Endocrinology|January 25, 2023
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral FormulationsSalman Z Bhat, Adrian S DobsFuture Oncology (London, England)|October 27, 2009
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexiaMihail F Zilbermint, Adrian S DobsJournal of Clinical Pharmacology|November 5, 2002
Endocrine effects of marijuanaTodd T Brown, Adrian S DobsCurrent Opinion in Endocrinology, Diabetes, and Obesity|February 21, 2013
The effect of androgens on lipidsAnne K Monroe, Adrian S DobsThe Journal of Clinical Endocrinology and Metabolism|February 11, 2026
Will Selective Androgen Receptor Modulators Ever Reach The Clinic?Jenny Pena Dias, Adrian S DobsDrugs|August 8, 2012
Topical testosterone supplementation for the treatment of male hypogonadismKatrina A Abadilla, Adrian S DobsCurrent Opinion in Endocrinology, Diabetes, and Obesity|October 18, 2007
Androgen deficiency, diabetes, and the metabolic syndrome in menRita R Kalyani, Adrian S DobsExpert Opinion on Pharmacotherapy|August 10, 2005
Nebido: a long-acting injectable testosterone for the treatment of male hypogonadismLindsey Harle, Shehzad Basaria, Adrian S DobsEndocrinology and Metabolism Clinics of North America|June 5, 2007
Male hypogonadism in systemic diseaseRita R Kalyani, Sravanya Gavini, Adrian S DobsPageof 12